Skip to main content
Premium Trial:

Request an Annual Quote

SIRS-Lab Licenses OGT Chip Technology to Develop, Market Arrays

NEW YORK, March 18 (GenomeWeb News) - SIRS-Lab of Jena, Germany, has licensed Oxford Gene Technology's DNA chip patents to makes its own arrays and distribute them in Europe, the company said yesterday.

Privately held SIRS-Lab is developing microarray systems for inflammatory diseases.

The company said that the IP complements its Lab-Arraytor products and allows for the expansion of the product portfolio for new applications.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.